期刊文献+

排石饮液对实验性高脂血症大鼠血脂的影响

Effects of lithagogue-drinking on blood lipid in rats with hyperlipidemia
下载PDF
导出
摘要 目的 观察排石饮液对实验性高脂血症大鼠血脂的影响。方法 通过 4周高脂饲料喂养 ,建立实验性高脂血症大鼠模型 ,观察预防性给予中药排石饮液对高脂血症大鼠血清胆固醇 (TC)、血清甘油三酯 (TG)、低密度脂蛋白胆固醇 (LDL C)和高密度脂蛋白胆固醇 (HDL C)的影响 ,同时对肝脏、心脏、主动脉进行肉眼和光镜病理组织学检查。结果 高脂血症模型组和各给药组血清TC、LDL C水平均高于正常对照组 ,排石饮液大剂量组血清TC、LDL C水平明显增高。病理组织学检查显示 ,模型组肝脏组织有明显脂肪变性 ,心脏组织可见脂肪细胞。排石饮液对肝脏脂肪变性无预防作用。结论  4周预防性应用排石饮液 ,对实验性高脂血症大鼠无降血脂作用 ,对肝脏脂肪变性无预防作用。 Objective To explore the effects of lithagogue drinking on blood lipid in rats with hyperlipidemia.Methods Experimental hyperlipidemic rat models were establish by raising them with high fat diet for 4 weeks, The effects of lithagogue drinking on TC,TG,LDL C and HDL C in hyperlipidemic rats were investigated.At the same time, the morphological changes of liver, heart and aorta were observed with naked eyes and optical microscope.Results The levels of TC,TG and LDL C in the serum among control group and each treatment group were significantly higher than that of normal group. Pathological histology inspection indicated that the liver tissue had obvious fatty degeneration and there were fatty cells in heart tissue in the control group. lithagogue drinking had no preventive role for liver fatty degeneration.Conclusion Lithagogue drinking is applied preventively for 4 weeks and there is no evidence that lithagogue drinking can reduce the level of serum lipid in experimental hyperlipidemic rats,or prevent liver fatty degeneration.contrary to our aim, lithagogue drinking of high dosage could promote hyperlipidemia.
出处 《哈尔滨医科大学学报》 CAS 2004年第2期143-145,共3页 Journal of Harbin Medical University
关键词 排石饮液 高脂血症 大鼠 血脂 心血管疾病 hyperlipidemia lithagogue drinking rat
  • 相关文献

参考文献9

二级参考文献10

  • 1姜德谦,文丹,祁述善,沈向前,周胜华.甘油三酯与高密度脂蛋白预测冠状动脉病变的意义[J].中华内科杂志,1995,34(5):298-301. 被引量:41
  • 2傅秀兰.复方红花治疗冠心病300例疗效观察[J].实用中西医结合杂志,1991,4(3):157-157.
  • 3徐长庆 杨宝峰 等.H2O2对豚鼠单个心室肌细胞动作电位和离子电流的影响[J].中国病理生理杂志,1998,14(7):896-896.
  • 4Kronmal RA, Cain KC, Ye Z, et al. Total serum cholesterol levels and mortality risk as a function of age.Arch Intern Med,1993,153:1065-1066.
  • 5Department of Internal Medicine. Yonezawa city hospital lipoprotein (a) is a potential coronary risk factor.JPN Cire J,2000,64:51-56.
  • 6Reder DJ, Brewer HB Jr. Lipoprotein(a). Clinical approach to a unique atherogenic lipoprotein. JAMA,1992,267 : 1109.
  • 7Cardiovascular Research Unit, Green Lane Hospital ,Auckland. Association of angiographically detected coronary artery disease with low levels of high -density lipoprotein cholesterol and systemic hypertension. Am J Cardiol, 1993,71 :505-510.
  • 8王天保,祝希媛,赵森林,汪宝琴,许大斐,李美茹,唐淑珍,卢炎,王征,周其善,郭馨,杨拥军,张金聚.注射异种蛋白质对实验性动脉粥样硬化形成的影响[J]北京医学,1981(01).
  • 9单宏丽,徐长庆,刘凤芝,李玉荣,杨宝峰,许宏远,娄延平.红花黄素对豚鼠单个心室肌细胞动作电位和钙电流的影响[J].中国药理学通报,1999,15(4):351-354. 被引量:56
  • 10陆宗良,李芬.冠心病患者血清载脂蛋白与脂质水平及临床意义[J].中国循环杂志,1991,6(6):544-546. 被引量:14

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部